Literature DB >> 16362638

Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

M Dumont1, R Lalonde, J-F Ghersi-Egea, K Fukuchi, C Strazielle.   

Abstract

In addition to Abeta plaques and neurofibrillary tangles, Alzheimer's disease (AD) is characterized by increased brain levels of APP C-terminal fragments. In the present investigation, the cholinergic innervation in forebrain regions of transgenic mice (Tg13592) expressing the human betaAPP C99 fragment was compared to that of non-transgenic controls by measuring the activity of the non-specific catabolic enzyme, acetylcholinesterase (AChE). The AchE activity of Tg13592 mice was altered in several regions implicated in the functional loop of regulation between septum and hippocampus, vulnerable in Alzheimer pathology and critically involved in cognitive functions. In particular, AChE activity was upregulated in three basal forebrain regions containing cholinergic cell bodies, prelimbic cortex, anterior subiculum, and paraventricular thalamus, but downregulated in lateral septum and reticular thalamus. The increased activity in medial septum and anterior subiculum was linearly correlated with poor performances in a spatial learning task, possibly due to cell stress mechanisms. Because of some similarities in terms of neurochemistry and behavior, this mouse model may be of use for studying prodromal AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362638     DOI: 10.1007/s00702-005-0373-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  78 in total

1.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

2.  Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis.

Authors:  J J Hagan; J D Salamone; J Simpson; S D Iversen; R G Morris
Journal:  Behav Brain Res       Date:  1988-01       Impact factor: 3.332

3.  Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes?

Authors:  R Hellweg; C Humpel; A Löwe; H Hörtnagl
Journal:  Brain Res Mol Brain Res       Date:  1997-04

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

5.  In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase.

Authors:  P Zatta; M Ibn-Lkhayat-Idrissi; P Zambenedetti; M Kilyen; T Kiss
Journal:  Brain Res Bull       Date:  2002-10-15       Impact factor: 4.077

6.  Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches.

Authors:  A Wevers; L Burghaus; N Moser; B Witter; O K Steinlein; U Schütz; B Achnitz; U Krempel; S Nowacki; K Pilz; J Stoodt; J Lindstrom; R A De Vos; E N Jansen Steur; H Schröder
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

7.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

8.  Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

Authors:  L R Fodero; S S Mok; D Losic; L L Martin; M I Aguilar; C J Barrow; B G Livett; D H Small
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

9.  Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice.

Authors:  Hans-Joachim Lüth; Jenny Apelt; Amadi O Ihunwo; Thomas Arendt; Reinhard Schliebs
Journal:  Brain Res       Date:  2003-07-04       Impact factor: 3.252

10.  Acetylcholinesterase activity and post-lesional plasticity in the hippocampus of young and aged rats.

Authors:  P Kugler; A Schleicher; K Zilles; E Horváth
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

View more
  5 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.

Authors:  Létitia Jean; Stephen Brimijoin; David J Vaux
Journal:  J Biol Chem       Date:  2019-02-20       Impact factor: 5.157

Review 3.  Physiological roles for amyloid beta peptides.

Authors:  Hugh A Pearson; Chris Peers
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

4.  Repeated gestational exposure to diesel engine exhaust affects the fetal olfactory system and alters olfactory-based behavior in rabbit offspring.

Authors:  Estefanía Bernal-Meléndez; Marie-Christine Lacroix; Pascaline Bouillaud; Jacques Callebert; Benoit Olivier; Marie-Annick Persuy; Didier Durieux; Delphine Rousseau-Ralliard; Josiane Aioun; Flemming Cassee; Anne Couturier-Tarrade; Sarah Valentino; Pascale Chavatte-Palmer; Henri Schroeder; Christine Baly
Journal:  Part Fibre Toxicol       Date:  2019-01-17       Impact factor: 9.400

5.  Dopaminergic and serotonergic changes in rabbit fetal brain upon repeated gestational exposure to diesel engine exhaust.

Authors:  Christine Baly; Henri Schroeder; Estefania Bernal-Meléndez; Jacques Callebert; Pascaline Bouillaud; Marie-Annick Persuy; Benoit Olivier; Karine Badonnel; Pascale Chavatte-Palmer
Journal:  Arch Toxicol       Date:  2021-06-29       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.